LICENSE AND SUBLICENSE AGREEMENTLicense and Sublicense Agreement • February 22nd, 2024 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations • California
This License and Sublicense Agreement (this “Agreement”) is entered into as of February 15, 2024 (the “Effective Date”) by Qualigen Therapeutics, Inc., a Delaware corporation (“QLGN”), on the one hand, and Pan-RAS Holdings, Inc., a New York corporation (“Pan-RAS”), on the other hand.
